![Chemical structure of 5H-Dibenz[b,f]azepine-5-propanamine, 3-chloro-10,11-dihydro-N,N-dimethyl-, CAS 303-49-1](https://api.angenesci.com/structure/387/303-49-1.png)
No data
No data
No data
| CAS Number | 303-49-1 |
| Catalog Number | AG002ZKJ(AGN-PC-0R5P7G) |
| Chemical Name | 5H-Dibenz[b,f]azepine-5-propanamine, 3-chloro-10,11-dihydro-N,N-dimethyl- |
| EC Number | 206-144-2 |
| IUPAC Name | 3-(2-chloro-5,6-dihydrobenzo[b][1]benzazepin-11-yl)-N,N-dimethylpropan-1-amine |
| InChI | InChI=1S/C19H23ClN2/c1-21(2)12-5-13-22-18-7-4-3-6-15(18)8-9-16-10-11-17(20)14-19(16)22/h3-4,6-7,10-11,14H,5,8-9,12-13H2,1-2H3 |
| InChI Key | GDLIGKIOYRNHDA-UHFFFAOYSA-N |
| MDL Number | MFCD00242755 |
| Molecular Formula | C19H23ClN2 |
| Molecular Weight | 314.8523 |
| NSC Number | 169865 |
| SMILES | CN(C)CCCN1C2=CC(Cl)=CC=C2CCC3=CC=CC=C31 |
| UNII | NUV44L116D |
| Synonyms | Anafranil,
Chlomipramine,
Chlorimipramine,
Clomipramine,
Clomipramine Hydrochloride,
Clomipramine Maleate (1:1),
Clomipramine Monohydrochloride,
Hydiphen,
Hydrochloride, Clomipramine,
Monohydrochloride, Clomipramine,
clomipramine,
Chlorimipramine,
303-49-1,
Monochlorimipramine,
3-Chloroimipramine,
Hydiphen,
Anafranil base,
Anafranil (free base),
3-(3-chloro-10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)-N,N-dimethylpropan-1-amine,
Clomipramina,
Clomipraminum,
Clomipraminum [INN-Latin],
Clomipramina [INN-Spanish],
Clomipramine [INN:BAN],
NSC 169865,
UNII-NUV44L116D,
3-Chloro-5-(3-(dimethylamino)propyl)-10,11-dihydro-5H-dibenz(b,f)azepine,
5H-Dibenz[b,f]azepine-5-propanamine, 3-chloro-10,11-dihydro-N,N-dimethyl-,
Anafranil (TN),
EINECS 206-144-2,
G 34586,
BRN 1323477,
NUV44L116D,
CHEBI:47780,
3-(3-CHLORO-5H-DIBENZO[B,F]AZEPIN-5-YL)-N,N-DIMETHYLPROPAN-1-AMINE,
5H-Dibenz(b,f)azepine, 10,11-dihydro-3-chloro-5-(3-(dimethylamino)propyl)-,
5H-Dibenz(b,f)azepine, 3-chloro-5-(3-(dimethylamino)propyl)-10,11-dihydro-,
5H-Dibenz(b,f)azepine-5-propanamine, 3-chloro-10,11-dihydro-N,N-dimethyl-,
3-(3-Chloro-10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)-N,N-dimethyl-1-propanamine,
NCGC00015264-08,
Chlomipramine,
AK122641,
DSSTox_CID_2844,
3-(2-chloro-5,6-dihydrobenzo[b][1]benzazepin-11-yl)-N,N-dimethylpropan-1-amine,
DSSTox_RID_76755,
DSSTox_GSID_22844,
G-34586,
3-(2-chloro-5,6-dihydrobenzo[b][1]benzazepin-11-yl)-N,N-dimethyl-propan-1-amine,
5H-Dibenz(b,f)azepine, 3-chloro-5-(3-(dimethylamino)propyl)-10,11-dihydro- (8CI),
CAS-303-49-1,
Clomipramine (INN),
CAS-17321-77-6,
3-chloro-5-(3-(dimethylamino)propyl)-10,11-dihydro-5H-dibenz[b,f]azepine,
HSDB 7746,
5H-Dibenz[b,f]azepine, 3-chloro-5-[3-(dimethylamino)propyl]-10,11-dihydro-,
CLOMIPRIMINE,
PubChem17200,
Spectrum_000444,
Tocris-0457,
AC1L1EHZ,
Prestwick0_000269,
Prestwick1_000269,
Prestwick2_000269,
Prestwick3_000269,
Spectrum2_001729,
Spectrum3_001707,
Spectrum4_000350,
Spectrum5_001235,
Lopac-C-7291,
Biomol-NT_000151,
CHEMBL415,
BIDD:PXR0151,
Lopac0_000307,
Oprea1_312582,
SCHEMBL35423,
BSPBio_000118,
BSPBio_003294,
KBioGR_000759,
KBioSS_000924,
5-20-08-00103 (Beilstein Handbook Reference),
cid_68539,
DivK1c_000797,
SPBio_001778,
SPBio_002337,
C14H12ClN.C6H15N,
BPBio1_000130,
BPBio1_000661,
GTPL2398,
DTXSID6022844,
BDBM77970,
KBio1_000797,
KBio2_000924,
KBio2_003492,
KBio2_006060,
KBio3_002514,
ZINC20248,
GDLIGKIOYRNHDA-UHFFFAOYSA-N,
NINDS_000797,
HMS3428J14,
Tox21_110117,
ACM303491,
BBL028455,
MFCD00242755,
NSC169865,
PDSP1_000241,
PDSP2_000240,
STK534842,
10,11-dihydro-3-chloro-5-(3-(dimethylamino)propyl)-5H-dibenz(b,f)azepine,
3-chloro-10,11-dihydro-N,N-dimethyl-5H-Dibenz(b,f)azepine-5-propanamine,
AKOS001487687,
Tox21_110117_1,
AB05476,
API0002067,
CCG-110307,
DB01242,
DS-6718,
MCULE-6443168248,
NSC-169865,
IDI1_000797,
NCGC00015264-01,
NCGC00015264-02,
NCGC00015264-03,
NCGC00015264-04,
NCGC00015264-05,
NCGC00015264-06,
NCGC00015264-07,
NCGC00015264-09,
NCGC00015264-10,
NCGC00015264-13,
NCGC00024355-02,
NCGC00024355-04,
NCGC00024355-05,
AJ-08424,
AN-44193,
LS-60386,
SC-80642,
SY246341,
SBI-0050295.P003,
AX8246819,
AB00053695,
MFCD31699980 (95%),
C06918,
D07727,
AB00053695-14,
AB00053695_15,
AB00053695_16,
303C491,
L000890,
3-Chloro-5-[3-(dimethylamino)propyl]-10,f]azepine,
5H-Dibenz[b, 3-chloro-10,11-dihydro-N,N-dimethyl-,
BRD-K52989797-001-01-1,
BRD-K52989797-003-05-8,
BRD-K52989797-003-16-5,
WLN: T C676 BN & T & J B3N1 & 1 EG,
5H-Dibenz[b, 10,11-dihydro-3-chloro-5-[3-(dimethylamino)propyl]-,
5H-Dibenz[b, 3-chloro-5-[3-(dimethylamino)propyl]-10,11-dihydro-,
3-(2-chloro-5,6-dihydrobenzo[b][1]benzazepin-11-yl)propyl-dimethyl-amine;hydrochloride,
3-(3-Chloro-10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)-N,N-dimethyl-1-propanamine #,
3-(9-chloro-5,6-dihydrobenzo[b][1]benzazepin-11-yl)-N,N-dimethylpropan-1-amine,
N,N-Dimethyl-7-chloro-10,11-dihydro-5H-dibenzo[b,f]azepine-5-propanamine-2,4-D2,
N-[3-(3-chloro-10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)propyl]-N,N-dimethylamine,
(3-{5-chloro-2-azatricyclo[9.4.0.0;{3,8}]pentadeca-1(11),3(8),4,6,12,14-hexaen-2-yl}propyl)dimethylamine,
2241983-11-7,
3-(2-chloranyl-5,6-dihydrobenzo[b][1]benzazepin-11-yl)-N,N-dimethyl-propan-1-amine;hydrochloride,
3-(2-chloro-5,6-dihydrobenzo[b][1]benzazepin-11-yl)-N,N-dimethyl-1-propanamine;hydrochloride,
Anafranil,
Clomicalm,
Clomipramine HCL,
Clomipramine hydrochloride,
D0ZS8P,
Hydrochloride, Clomipramine,
C19H23ClN2,
Clomipramine Monohydrochloride,
Clomipramine Maleate (1:1),
MLS000028511,
Monohydrochloride, Clomipramine,
C19-H23-Cl-N2,
CID2801,
SMR000058295,
C(CCN(C)C)N1c2ccccc2CCc3ccc(Cl)cc13,
D002997,
3-Chloro-5-[3-(dimethylamino)propyl]-10,11-dihydro-5H-dibenz[b,f]azepine,
3-CHLORO-10,11-DIHYDRO-N,N-DIMETHYL-5H-DIBENZ[B,F]AZEPINE-5-PROPANAMINE,
5H-Dibenz(b,f)azepine, 3-chloro-5-(3-(dimethylamino)propyl)-10,11-dihydro-(8CI),
3-(2-chloro-5,6-dihydrobenzo[b][1]benzazepin-11-yl)-N,N-dimethylpropan-1-amine;hydrochloride,
CXX,
|
| Complexity | 346 |
| Compound Is Canonicalized | Yes |
| Covalently-Bonded Unit Count | 1 |
| Defined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Exact Mass | 314.155g/mol |
| Formal Charge | 0 |
| Heavy Atom Count | 22 |
| Hydrogen Bond Acceptor Count | 2 |
| Hydrogen Bond Donor Count | 0 |
| Isotope Atom Count | 0 |
| Molecular Weight | 314.857g/mol |
| Monoisotopic Mass | 314.155g/mol |
| Rotatable Bond Count | 4 |
| Topological Polar Surface Area | 6.5A^2 |
| Undefined Atom Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| XLogP3 | 5.2 |
| Symbol: | |
| Hazard Class | 8 |
| Hazard statements | H227-H314 |
| Packing Group | Ⅱ |
| Precautionary statements | P280-P305+P351+P338-P310 |
| UN Code | UN 3265 |
| Chemical Name: | Batch Number: | |
| Chemical Structure: | CAS Registry No: | |
| Product ID: | ||
| Manufacture Date: | ||
| Storage Temperature: | ||
| Formula: | ||
| Molecular Weight: | ||
| Quantity: |
| Test: | Result: |

